COST PLUS FIXED FEE

LOVELACE BIOMEDICAL RESEARCH INSTITUTE - GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY

PIID: 75N92023F00001

Signed Date: Feb 23, 2026Effective Date: Sep 25, 2023End Date: Closed on Jun 30, 2024

Award $

$172K

Vendor

LOVELACE BIOMEDICAL RESEARCH INSTITUTE

NAICS

541714

Signed Date

Feb 23, 2026

Key Details

Dollars Obligated

$171,741.89

Base & All Options

$-62,736.11

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

ALBUQUERQUE, NM, 871085129, CD-NM-01

GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY

On Feb 23, 2026, Department of Health and Human Services obligated $171,741.89 to LOVELACE BIOMEDICAL RESEARCH INSTITUTE for gene therapy resource program (gtrp): pharmacology and toxicology core laboratory. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in ALBUQUERQUE, NM. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.